Loading...
•
Mar 31, 2020
NeoGenomics Q1 2020 Earnings Report
NeoGenomics reported an 11% increase in revenue, reaching $106 million.
Key Takeaways
NeoGenomics, Inc. reported an 11% increase in consolidated revenue to $106.0 million for the first quarter of 2020. Clinical Services revenue increased by 7.9% to $93.0 million, while Pharma Services revenue grew by 39.3% to $13.0 million. The company experienced a net loss of $7.0 million, compared to a net loss of $2.4 million in the first quarter of 2019.
Consolidated revenue increased 10.9% to $106.0 million.
Clinical Services revenue increased 7.9% to $93.0 million.
Pharma Services revenue increased 39.3% to $13.0 million.
Pharma Services backlog increased 46.5% to $147.7 million.
Forward Guidance
The long-term growth outlook remains compelling and the company expects to emerge from this situation stronger than ever.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...